BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 11760925)

  • 1. A comparative study on schizophrenic patients with dual diagnosis.
    Modestin J; Gladen CJ; Christen S
    J Addict Dis; 2001; 20(4):41-51. PubMed ID: 11760925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comorbid substance use disorder in schizophrenia: a selective overview of neurobiological and cognitive underpinnings.
    Thoma P; Daum I
    Psychiatry Clin Neurosci; 2013 Sep; 67(6):367-83. PubMed ID: 23890122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders.
    Brunette MF; Noordsy DL; Xie H; Drake RE
    Psychiatr Serv; 2003 Oct; 54(10):1395-401. PubMed ID: 14557527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative study of substance dependence comorbidity in bipolar, schizophrenic and schizoaffective disorders].
    Verdoux H; Mury M; Besançon G; Bourgeois M
    Encephale; 1996; 22(2):95-101. PubMed ID: 8706627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in substance abuse patterns: multiple drug abuse alone versus schizophrenia with multiple drug abuse.
    Lammertink M; Löhrer F; Kaiser R; Hambrecht M; Pukrop R
    Acta Psychiatr Scand; 2001 Nov; 104(5):361-6. PubMed ID: 11722317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug abuse in schizophrenic patients: clinical correlates and reasons for use.
    Dixon L; Haas G; Weiden PJ; Sweeney J; Frances AJ
    Am J Psychiatry; 1991 Feb; 148(2):224-30. PubMed ID: 1987823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Courses of substance use and schizophrenia in the dual-diagnosis patients: is there a relationship?
    Goswami S; Singh G; Mattoo SK; Basu D
    Indian J Med Sci; 2003 Aug; 57(8):338-46. PubMed ID: 12944690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of potentially abusive psychotropic substances in psychiatric inpatients.
    Modestin J; Nussbaumer C; Angst K; Scheidegger P; Hell D
    Eur Arch Psychiatry Clin Neurosci; 1997; 247(3):146-53. PubMed ID: 9224907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dual diagnosis in psychiatric inpatients: prevalence and general characteristics].
    Rodríguez-Jiménez R; Aragüés M; Jiménez-Arriero MA; Ponce G; Muñoz A; Bagney A; Hoenicka J; Palomo T
    Invest Clin; 2008 Jun; 49(2):195-205. PubMed ID: 18717266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotic drug treatment of schizophrenic patients with substance abuse disorders.
    San L; Arranz B; Martinez-Raga J
    Eur Addict Res; 2007; 13(4):230-43. PubMed ID: 17851245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cannabis and schizophrenia: demographic and clinical correlates].
    Dervaux A; Laqueille X; Bourdel MC; Leborgne MH; Olié JP; Lôo H; Krebs MO
    Encephale; 2003; 29(1):11-7. PubMed ID: 12640322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The vulnerability to alcohol and substance abuse in individuals diagnosed with schizophrenia.
    Krystal JH; D'Souza DC; Gallinat J; Driesen N; Abi-Dargham A; Petrakis I; Heinz A; Pearlson G
    Neurotox Res; 2006 Dec; 10(3-4):235-52. PubMed ID: 17197373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of substance abuse in schizophrenia: nature and significance.
    DeQuardo JR; Carpenter CF; Tandon R
    J Psychiatr Res; 1994; 28(3):267-75. PubMed ID: 7932286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlates of patterns of substance abuse among patients with schizophrenia.
    Cuffel BJ; Heithoff KA; Lawson W
    Hosp Community Psychiatry; 1993 Mar; 44(3):247-51. PubMed ID: 8444435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Schizophrenia and substance dependence].
    Uchtenhagen A
    Schweiz Arch Neurol Psychiatr (1985); 1995; 146(5):215-23. PubMed ID: 8658102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Schizophrenia and addiction: An evaluation of the self-medication hypothesis].
    Potvin S; Stip E; Roy JY
    Encephale; 2003; 29(3 Pt 1):193-203. PubMed ID: 12876543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neuropsychology of cannabis and other substance use in schizophrenia: review of the literature and critical evaluation of methodological issues.
    Coulston CM; Perdices M; Tennant CC
    Aust N Z J Psychiatry; 2007 Nov; 41(11):869-84. PubMed ID: 17924240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships between symptoms of schizophrenia and substance abuse.
    Brunette MF; Mueser KT; Xie H; Drake RE
    J Nerv Ment Dis; 1997 Jan; 185(1):13-20. PubMed ID: 9040528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabis and schizophrenia: results of a follow-up study.
    Caspari D
    Eur Arch Psychiatry Clin Neurosci; 1999; 249(1):45-9. PubMed ID: 10195343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anhedonia and social adaptation predict substance abuse evolution in dual diagnosis schizophrenia.
    Potvin S; Stip E; Lipp O; Roy MA; Demers MF; Bouchard RH; Gendron A
    Am J Drug Alcohol Abuse; 2008; 34(1):75-82. PubMed ID: 18161645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.